Ashay Jain

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (26)

• Emerging therapeutic landscape on delivery of oxytocin to brain for treating neurological disorders
  Journal of Drug Delivery Science and Technology 2024 DOI: 10.1016/j.jddst.2024.105370
  +Save
• Recent progress in macromolecules: From current therapeutic strategies to theranostic applications
  Journal of Drug Delivery Science and Technology 2024 DOI: 10.1016/j.jddst.2024.105664
  +Save
• Novel Discoveries and Clinical Advancements for Treating Onychomycosis: A Mechanistic Insight.
  Advanced drug delivery reviews 2023 DOI: 10.1016/j.addr.2023.115174
  +Save
• Nanocarriers mediated delivery of methotrexate is instrumental in treating auto-immune diseases and cancer
  Journal of Drug Delivery Science and Technology 2023 DOI: 10.1016/j.jddst.2023.104969
  +Save
• Beta-carotene-Encapsulated Solid Lipid Nanoparticles (BC-SLNs) as Promising Vehicle for Cancer: an Investigative Assessment.
  AAPS PharmSciTech 2019 DOI: 10.1208/s12249-019-1301-7
  +Save
• Lanolin-based organogel of salicylic acid: evidences of better dermatokinetic profile in imiquimod-induced keratolytic therapy in BALB/c mice model.
  Drug delivery and translational research 2018 DOI: 10.1007/s13346-017-0364-9
  +Save
• Lycopene loaded whey protein isolate nanoparticles: An innovative endeavor for enhanced bioavailability of lycopene and anti-cancer activity.
  International journal of pharmaceutics 2018 DOI: 10.1016/j.ijpharm.2018.04.061
  +Save
• Cationic-bilayered nanoemulsion of fusidic acid: an investigation on eradication of methicillin-resistant Staphylococcus aureus 33591 infection in burn wound.
  Nanomedicine (London, England) 2018 DOI: 10.2217/nnm-2017-0227
  +Save
• Administration of antioxidants in cancer: debate of the decade.
  Drug discovery today 2018 DOI: 10.1016/j.drudis.2018.01.021
  +Save
• Beta carotene-loaded zein nanoparticles to improve the biopharmaceutical attributes and to abolish the toxicity of methotrexate: a preclinical study for breast cancer.
  Artificial cells, nanomedicine, and biotechnology 2018 DOI: 10.1080/21691401.2018.1428811
  +Save